Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era.
作者信息
Rossouw Jacques E
出版信息
Maturitas. 2010 Mar;65(3):179-80. doi: 10.1016/j.maturitas.2009.11.012. Epub 2009 Dec 9.
Abstract
摘要
相似文献
1
Prescribing postmenopausal hormone therapy to women in their 50s in the post-Women's Health Initiative era.在“妇女健康倡议”（Women's Health Initiative）之后的时代，为50多岁的女性开具绝经后激素疗法的处方。
Maturitas. 2010 Mar;65(3):179-80. doi: 10.1016/j.maturitas.2009.11.012. Epub 2009 Dec 9.
2
Hormone replacement therapy: short-term versus long-term use.激素替代疗法：短期使用与长期使用
J Midwifery Womens Health. 2002 Nov-Dec;47(6):461-70. doi: 10.1016/s1526-9523(02)00352-5.
3
Health risks after cessation of postmenopausal hormone therapy.绝经后激素治疗停止后的健康风险。
Climacteric. 2008 Jun;11(3):179-80. doi: 10.1080/13697130802176228.
4
Perspectives on the Women's Health Initiative trial of hormone replacement therapy.关于女性健康倡议激素替代疗法试验的观点
Obstet Gynecol. 2002 Dec;100(6):1344-53. doi: 10.1016/s0029-7844(02)02503-6.
5
Lessons learned from the WHI: HRT requires a cautious and individualized approach.从妇女健康倡议（WHI）中吸取的教训：激素替代疗法（HRT）需要谨慎且个体化的方法。
Geriatrics. 2004 Nov;59(11):22-6.
6
Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?女性健康倡议研究前后的绝经后激素治疗：有哪些后果？
Ann Med. 2004;36(6):402-13. doi: 10.1080/07853890410035430.
7
Clinical practice. Postmenopausal hormone-replacement therapy.临床实践。绝经后激素替代疗法。
N Engl J Med. 2001 Jul 5;345(1):34-40. doi: 10.1056/NEJM200107053450106.
8
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.绝经后长期雌激素国际女性研究（WISDOM）中记录的主要发病率：一项绝经后女性激素替代疗法的随机对照试验。
BMJ. 2007 Aug 4;335(7613):239. doi: 10.1136/bmj.39266.425069.AD. Epub 2007 Jul 11.
9
A personal initiative for women's health: to challenge the Women's Health Initiative.一项针对女性健康的个人倡议：挑战女性健康倡议组织。
Gynecol Endocrinol. 2002 Aug;16(4):255-7.
10
The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.《妇女健康倡议随机试验和临床实践：综述》。
JAMA. 2024 May 28;331(20):1748-1760. doi: 10.1001/jama.2024.6542.
引用本文的文献
1
Targeting the non-classical estrogen pathway in neurodegenerative diseases and brain injury disorders.靶向神经退行性疾病和脑损伤疾病的非经典雌激素途径。
Front Endocrinol (Lausanne). 2022 Sep 15;13:999236. doi: 10.3389/fendo.2022.999236. eCollection 2022.
2
Letter to the editor.
Menopause. 2010 Oct 20;17(6):1207-8. doi: 10.1097/gme.0b013e3181f7dd34.
本文引用的文献
1
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.绝经后不久开始进行激素治疗的益处与风险。
Am J Epidemiol. 2009 Jul 1;170(1):12-23. doi: 10.1093/aje/kwp115. Epub 2009 May 25.
2
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.类似随机试验那样分析的观察性研究：绝经后激素治疗与冠心病的应用
Epidemiology. 2008 Nov;19(6):766-79. doi: 10.1097/EDE.0b013e3181875e61.
3
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.绝经后激素治疗与心血管疾病风险随年龄及绝经年限的变化
JAMA. 2007 Apr 4;297(13):1465-77. doi: 10.1001/jama.297.13.1465.
4
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.结合马雌激素对子宫切除术后绝经后女性的影响：女性健康倡议随机对照试验
JAMA. 2004 Apr 14;291(14):1701-12. doi: 10.1001/jama.291.14.1701.
5
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.健康绝经后妇女使用雌激素加孕激素的风险与益处：妇女健康倡议随机对照试验的主要结果
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
6
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.雌激素加孕激素用于绝经后妇女冠心病二级预防的随机试验。心脏与雌激素/孕激素替代研究（HERS）研究组
JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605.
Zotero 插件